Delivery Order SPE2DR25D1109-SPE2DR26FFJ3S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,352.71. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Phenobarbital 130 mg/ml in vial form, with a contract ceiling value of $2,611.73 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $3,410.16 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Phenobarbital 130 mg/mL in vial form. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for the award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials valued at $3,749.73 on September 29, 2025. This firm fixed-price, competitively awarded delivery order is non-set-aside and scheduled for completion by September 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a continuation of the company's substantial pharmaceutical supply relationship with the federal...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitive, firm fixed-price delivery order carries a ceiling value of $3,285.27 and has an ultimate completion date of September 26, 2025. The contract involves no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $3,106.84. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement, specifically supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,133.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,494.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of April 8, 2025. This firm fixed price delivery order, awarded on April 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,149.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Phenobarbital 130 mg/mL vials. This is a non-set-aside contract with an ultimate completion date of May 22, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ3SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Phenobarbital 130 mg/ml vials with a ceiling value of $3,839.58. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal procurement markets. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle supports the military healthcare supply chain globally, enabling AmerisourceBergen to deliver a comprehensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive federal contract portfolio with DLA, supplying specialty medications, vaccines, and medical commodities across multiple therapeutic domains to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/18/25 |